These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 564259)

  • 1. The effect of L-dopa and lergotrile mesylate on the interaction of fluphenazine decanoate and amphetamine-induced stereotypy and mortality.
    Lemberger L; Kellams JJ; Small JG; Rowe H
    Commun Psychopharmacol; 1977; 1(5):501-7. PubMed ID: 564259
    [No Abstract]   [Full Text] [Related]  

  • 2. Stimulant properties of bromocriptine on central dopamine receptors in comparison to apomorphine, (+)-amphetamine and L-DOPA.
    Johnson AM; Loew DM; Vigouret JM
    Br J Pharmacol; 1976 Jan; 56(1):59-68. PubMed ID: 943193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stereotyped responses of rats to two 2-halogenoergolines: 2-bromo-alpha-ergocryptine and lergotrile.
    Bergmann F
    Isr J Med Sci; 1982 Jan; 18(1):177-82. PubMed ID: 6121772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of angiotensin on the central action of dopamine.
    Braszko J; Wiśniewski K
    Pol J Pharmacol Pharm; 1976; 28(6):667-72. PubMed ID: 1034924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of chronic amphetamine exposure on stereotyped behavior: implications for pathogenesis of l-dopa-induced dyskinesias.
    Klawans HL; Crossett P; Dana N
    Adv Neurol; 1975; 9():105-12. PubMed ID: 1170714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effects of three dopamine agonists: apomorphine, bromocriptine and lergotrile.
    Silbergeld EK; Pfeiffer RF
    J Neurochem; 1977 Jun; 28(6):1323-6. PubMed ID: 577501
    [No Abstract]   [Full Text] [Related]  

  • 7. [The influence of atropine on the antiamphetaminic action of fluphenazine (author's transl)].
    Rechberger T; Turski L; Turski W; Wójcik E
    Ann Univ Mariae Curie Sklodowska Med; 1979; 34():333-9. PubMed ID: 263620
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of dopamine agonists on Cebus apella monkeys with previous long-term exposure to fluphenazine.
    Lifshitz K; O'Keeffe RT; Linn GS; Lee KL; Camp-Bruno JA; Suckow RF
    Biol Psychiatry; 1997 Mar; 41(6):657-67. PubMed ID: 9066989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of apomorphine, bromocriptine and Sandoz CM 29-712 (6-methyl-8a-cyanomethyl-ergoline-l) in four different turning models in the rat [proceedings].
    Jaton AL; Loew DM; Vigouret JM
    Br J Pharmacol; 1978 Mar; 62(3):395P. PubMed ID: 565235
    [No Abstract]   [Full Text] [Related]  

  • 10. Endogenous neurotensin attenuates dopamine-dependent locomotion and stereotypy.
    Chartoff EH; Szczypka MS; Palmiter RD; Dorsa DM
    Brain Res; 2004 Oct; 1022(1-2):71-80. PubMed ID: 15353215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of levodopa, lergotrile, and bromocriptine on brain iron, manganese, and copper.
    Weiner WJ; Nausieda PA; Klawans HL
    Neurology; 1978 Jul; 28(7):734-7. PubMed ID: 566875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methodone interaction with apomorphine- and amphetamine-induced turning.
    Stratten WP
    Res Commun Chem Pathol Pharmacol; 1975 Aug; 11(4):675-8. PubMed ID: 1237160
    [No Abstract]   [Full Text] [Related]  

  • 13. [The influence of trihexyphenidyl on the antiamphetaminic action of fluphenazine (author's transl)].
    Kleinrok Z; Ossowska G
    Ann Univ Mariae Curie Sklodowska Med; 1979; 34():341-5. PubMed ID: 263621
    [No Abstract]   [Full Text] [Related]  

  • 14. Stereotypy following acute administration of l-alpha-acetylmethadol (LAAM) in the rat.
    Henderson GL; Westkaemper R
    Proc West Pharmacol Soc; 1975; 18():204-7. PubMed ID: 1237140
    [No Abstract]   [Full Text] [Related]  

  • 15. Influence of adenosine receptor agonists and antagonists on amphetamine-induced stereotypy in rats.
    Poleszak E; Malec D
    Pol J Pharmacol; 2000; 52(6):423-9. PubMed ID: 11334236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of neuroleptic drugs on mouse jumping induced by L-DOPA in amphetamine treated mice.
    Lal H; Marky M; Fielding S
    Neuropharmacology; 1976 Nov; 15(11):669-71. PubMed ID: 1034243
    [No Abstract]   [Full Text] [Related]  

  • 17. The influence of insulin hypoglycemia on central dopaminergic structures of the rat.
    Kleinrok Z; Ossowska G; Stelmasiak M; Juszkiewicz M
    Pol J Pharmacol Pharm; 1983; 35(6):489-95. PubMed ID: 6377282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of a strong influence of neuroleptic decanoates on dopaminergic and GABAergic functions.
    Ossowska K; Wolfarth S
    Pol J Pharmacol; 1995; 47(2):99-107. PubMed ID: 8688897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction between bromocriptine and levodopa. Biochemical basis for an improved treatment for parkinsonism.
    Hutt CS; Snider SR; Fahn S
    Neurology; 1977 Jun; 27(6):503-10. PubMed ID: 577299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circadian-dependent effect of melatonin on dopaminergic D2 antagonist-induced hypokinesia and agonist-induced stereotypies in rats.
    Sumaya IC; Byers DM; Irwin LN; Del Val S; Moss DE
    Pharmacol Biochem Behav; 2004 Aug; 78(4):727-33. PubMed ID: 15301928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.